id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-288919-3ay39zf5	Müller, Helmut	Recovery from COVID‐19 following hepatitis C, human immunodeficiency virus infection, and liver transplantation	2020-06-18		.txt	text/plain	231	22	42	key: cord-288919-3ay39zf5 title: Recovery from COVID‐19 following hepatitis C, human immunodeficiency virus infection, and liver transplantation cord_uid: 3ay39zf5 Immunosuppression and frequent comorbidities in transplant recipients potentially increase the risk of fatal outcomes of pandemic coronavirus disease 2019 (COVID-19) [1]. In the nineteen-seventies, he acquired hepatitis C virus (HCV) infection, probably via factor VIII supplementation, and in 1985 human immunodeficiency virus (HIV) infection. HIV suppression with repeatedly negative PCR results has been achieved. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation Fatal outcome in a liver transplant recipient with COVID-19 The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.	./cache/cord-288919-3ay39zf5.txt	./txt/cord-288919-3ay39zf5.txt